Krüppel-like transcription factor 16 transcriptional up-regulation of cellular retinoic acid-binding proteins-2 promotes the invasion and migration and inhibits apoptosis of retinoblastoma cells by regulating integrin-β1/focal adhesion kinase /extracellular signal-regulated kinase pathway

References

• Dimaras H, Corson TW, Cobrinik D, et al. Retinoblastoma. Nat Rev Dis Primers. 2015;1(1):15021.
   PubMedGoogle Scholar
• Abramson DH, Schefler AC. Update on retinoblastoma. Retina (Philadelphia, Pa). 2004;24(6):828–848.
   PubMed Web of Science ®Google Scholar
• Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971;68(4):820–823.
   PubMed Web of Science ®Google Scholar
• Broaddus E, Topham A, Singh AD. Incidence of retinoblastoma in the USA: 1975-2004. Br J Ophthalmol. 2009;93(1):21–23.
   PubMed Web of Science ®Google Scholar
• Leal-Leal C, Flores-Rojo M, Medina-Sansón A, et al. A multicentre report from the Mexican retinoblastoma group. Br J Ophthalmol. 2004;88(8):1074–1077.
   PubMed Web of Science ®Google Scholar
• Naseripour M, Nazari H, Bakhtiari P, et al. Retinoblastoma in Iran: outcomes in terms of patients’ survival and globe survival. Br J Ophthalmol. 2009;93(1):28–32.
   PubMed Web of Science ®Google Scholar
• Seregard S, Lundell G, Svedberg H, et al. Incidence of retinoblastoma from 1958 to 1998 in Northern Europe: advantages of birth cohort analysis. Ophthalmology. 2004;111(6):1228–1232.
   PubMed Web of Science ®Google Scholar
• Kivelä T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol. 2009;93(9):1129–1131.
   PubMed Web of Science ®Google Scholar
• Chantada GL, Qaddoumi I, Canturk S, et al. Strategies to manage retinoblastoma in developing countries. Pediatr Blood Cancer. 2011;56(3):341–348.
   PubMed Web of Science ®Google Scholar
• Canturk S, Qaddoumi I, Khetan V, et al. Survival of retinoblastoma in less-developed countries impact of socioeconomic and health-related indicators. Br J Ophthalmol. 2010;94(11):1432–1436.
   PubMed Web of Science ®Google Scholar
• Golabchi K, Soleimani-Jelodar R, Aghadoost N, et al. MicroRNAs in retinoblastoma: potential diagnostic and therapeutic biomarkers. J Cell Physiol. 2018;233(4):3016–3023.
   PubMed Web of Science ®Google Scholar
• Mallikarjuna K, Sundaram CS, Sharma Y, et al. Comparative proteomic analysis of differentially expressed proteins in primary retinoblastoma tumors. Proteomics Clin Appl. 2010;4(4):449–463.
   PubMed Web of Science ®Google Scholar
• Sessler RJ, Noy N. A ligand-activated nuclear localization signal in cellular retinoic acid binding protein-II. Mol Cell. 2005;18(3):343–353.
   PubMed Web of Science ®Google Scholar
• Delva L, Bastie JN, Rochette-Egly C, et al. Physical and functional interactions between cellular retinoic acid binding protein II and the retinoic acid-dependent nuclear complex. Mol Cell Biol. 1999;19(10):7158–7167.
   PubMed Web of Science ®Google Scholar
• Kim DJ, Kim WJ, Lim M, et al. Plasma CRABP2 as a novel biomarker in patients with non-small cell lung cancer. J Korean Med Sci. 2018;33(26):e178.
   PubMed Web of Science ®Google Scholar
• Chen Q, Tan L, Jin Z, et al. Downregulation of CRABP2 inhibit the tumorigenesis of hepatocellular carcinoma in vivo and in vitro. Biomed Res Int. 2020;2020:3098327.
   PubMed Web of Science ®Google Scholar
• Fornes O, Castro-Mondragon JA, Khan A, et al. JASPAR 2020: update of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 2020;48(D1):D87–d92.
   PubMed Web of Science ®Google Scholar
• Daftary GS, Lomberk GA, Buttar NS, et al. Detailed structural-functional analysis of the Krüppel-like factor 16 (KLF16) transcription factor reveals novel mechanisms for silencing Sp/KLF sites involved in metabolism and endocrinology. J Biol Chem. 2012;287(10):7010–7025.
   PubMed Web of Science ®Google Scholar
• Huang ZH, Luo WZ, Cai XD. Clinical significance of KLF16 expression in patients with lung adenocarcinoma. Chin J Physiol. 2013;29(11):1978–1983.
   Google Scholar
• Zhang JX, Yan XJ, Wu S, et al. KLF16 overexpression deleteriously affects the proliferation and migration of retinoblastoma by transcriptionally repressing BCL2L15. Biochem Biophys Res Commun. 2020;529(4):977–983.
   PubMed Web of Science ®Google Scholar
• Wu JI, Lin YP, Tseng CW, et al. Crabp2 promotes metastasis of lung cancer cells via HuR and Integrin β1/FAK/ERK signaling. Sci Rep. 2019;9(1):845.
   PubMedGoogle Scholar
• Jahan R, Macha MA, Rachagani S, et al. Axed MUC4 (MUC4/X) aggravates pancreatic malignant phenotype by activating integrin-β1/FAK/ERK pathway. Biochim Biophys Acta Mol Basis Dis. 2018;1864(8):2538–2549.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods (San Diego. Calif). 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Yang XL, Hao YJ, Wang B, et al. Long noncoding RNA NORAD promotes the progression of retinoblastoma by sponging miR 136-5p/PBX3 axis. Eur Rev Med Pharmacol Sci. 2020;24(8):4055.
   PubMed Web of Science ®Google Scholar
• Sun X, Shen H, Liu S, et al. Long noncoding RNA SNHG14 promotes the aggressiveness of retinoblastoma by sponging microRNA‑124 and thereby upregulating STAT3. Int J Mol Med. 2020;45(6):1685–1696.
   PubMed Web of Science ®Google Scholar
• Percicote AP, Mardegan GL, Gugelmim ES, et al. Tissue expression of retinoic acid receptor alpha and CRABP2 in metastatic nephroblastomas. Diagn Pathol. 2018;13(1):9.
   PubMedGoogle Scholar
• McGrane MM. Vitamin A regulation of gene expression: molecular mechanism of a prototype gene. J Nutr Biochem. 2007;18(8):497–508.
   PubMed Web of Science ®Google Scholar
• Okuducu AF, Janzen V, Ko Y, et al. Cellular retinoic acid-binding protein 2 is down-regulated in prostate cancer. Int J Oncol. 2005;27(5):1273–1282.
   PubMed Web of Science ®Google Scholar
• Calmon MF, Rodrigues RV, Kaneto CM, et al. Epigenetic silencing of CRABP2 and MX1 in head and neck tumors. Neoplasia. 2009;11(12):1329–1339.
   PubMed Web of Science ®Google Scholar
• Yang Q, Wang R, Xiao W, et al. Cellular retinoic acid binding protein 2 is strikingly downregulated in human esophageal squamous cell carcinoma and functions as a tumor suppressor. PLoS One. 2016;11(2):e0148381.
   PubMed Web of Science ®Google Scholar
• Xiao W, Hong H, Awadallah A, et al. CRABP-II is a highly sensitive and specific diagnostic molecular marker for pancreatic ductal adenocarcinoma in distinguishing from benign pancreatic conditions. Hum Pathol. 2014;45(6):1177–1183.
   PubMed Web of Science ®Google Scholar
• Takahashi M, Yang XJ, Lavery TT, et al. Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features. Cancer Res. 2002;62(22):6598–6605.
   PubMed Web of Science ®Google Scholar
• Abdelmohsen K, Gorospe M. Posttranscriptional regulation of cancer traits by HuR. Wiley Interdiscip Rev RNA. 2010;1(2):214–229.
   PubMed Web of Science ®Google Scholar
• Vreeland AC, Levi L, Zhang W, et al. Cellular retinoic acid-binding protein 2 inhibits tumor growth by two distinct mechanisms. J Biol Chem. 2014;289(49):34065–34073.
   PubMed Web of Science ®Google Scholar
• Vreeland AC, Yu S, Levi L, et al. Transcript stabilization by the RNA-binding protein HuR is regulated by cellular retinoic acid-binding protein 2. Mol Cell Biol. 2014;34(12):2135–2146.
   PubMed Web of Science ®Google Scholar
• Wu JI, Lin YP, Tseng CW, et al. Crabp2 promotes metastasis of lung cancer cells via HuR and Integrin beta1/FAK/ERK signaling. Sci Rep. 2019;9(1):845.
   PubMedGoogle Scholar
• Mukherjee N, Lager PJ, Friedersdorf MB, et al. Coordinated posttranscriptional mRNA population dynamics during T-cell activation. Mol Syst Biol. 2009;5(1):288.
   PubMedGoogle Scholar
• Frisch SM, Vuori K, Ruoslahti E, et al. Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol. 1996;134(3):793–799.
   PubMed Web of Science ®Google Scholar
• Collins NL, Reginato MJ, Paulus JK, et al. G1/S cell cycle arrest provides anoikis resistance through Erk-mediated Bim suppression. Mol Cell Biol. 2005;25(12):5282–5291.
   PubMed Web of Science ®Google Scholar
• Miyazaki T, Kato H, Nakajima M, et al. FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma. Br J Cancer. 2003;89(1):140–145.
   PubMed Web of Science ®Google Scholar
• Guo W, Giancotti FG. Integrin signalling during tumour progression. Nat Rev Mol Cell Biol. 2004;5(10):816–826.
   PubMed Web of Science ®Google Scholar
• Grzesiak JJ, Tran Cao HS, Burton DW, et al. Knockdown of the β(1) integrin subunit reduces primary tumor growth and inhibits pancreatic cancer metastasis. Int J Cancer. 2011;129(12):2905–2915.
   PubMed Web of Science ®Google Scholar
• Bouchard V, Harnois C, Demers MJ, et al. B1 integrin/Fak/Src signaling in intestinal epithelial crypt cell survival: integration of complex regulatory mechanisms. Apoptosis. 2008;13(4):531–542.
   PubMed Web of Science ®Google Scholar
• Hazlehurst LA, Damiano JS, Buyuksal I, et al. Adhesion to fibronectin via beta1 integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR). Oncogene. 2000;19(38):4319–4327.
   PubMed Web of Science ®Google Scholar
• Reddig PJ, Juliano RL. Clinging to life: cell to matrix adhesion and cell survival. Cancer Metastasis Rev. 2005;24(3):425–439.
   PubMed Web of Science ®Google Scholar